BioTech/Drugs - Boulder, CO, US
Viridian Therapeutics is a biotechnology company advancing new treatments for patients suffering from serious diseases but underserved by today's therapies. Viridian's most advanced program, VRDN-001, is a clinical-stage anti-IGF-1R monoclonal antibody in development for thyroid eye disease (TED). Viridian is headquartered in Boulder, Colo., with research and development operations in Waltham, Mass. and amazing remote staff across the country.
Outlook
BugHerd
WP Engine
Google Cloud Hosting
Adobe Marketing Cloud
Bootstrap Framework